scorecardresearch
Add as a preferred source on Google
Sunday, February 22, 2026
TopicSun Pharma

Topic: Sun Pharma

Gujarat to get Rs 150 cr leadership institute—Modi’s brainchild, backed by India’s top Industry leaders

Former finance secretary Hashmukh Adhia has been appointed the chairman of the executive committee of School of Ultimate Leadership (SOUL).

US drug regulator halts Sun Pharma trials on dermatological drug

Sun Pharma, India's largest drugmaker by revenue, acquired deuruxolitinib when it bought US-based Concert Pharmaceuticals for $576 million earlier this year.

US FDA asks India’s Sun Pharma to halt trials on experimental dermatological drug

Sun Pharma said FDA has also stated that patients with alopecia areata on 12 mg dose of the drug deuruxolitinib should discontinue its use, Sun Pharma said.

Sun Pharmaceutical flags revenue drop in its businesses due to ‘IT security incident’

The incident’s effect included breach of certain file systems and theft of some company and personal data, Sun Pharma said in a filing on Sunday.

Sun Pharma gets approval to test pancreatitis drug nafamostat for Covid treatment

Sun Pharma says nafamostat has shown promise in fighting against the virus in in-vitro studies conducted by 3 groups of scientists in Europe, Japan and South Korea.

China’s war on healthcare costs opens big window for India’s Sun Pharmaceuticals

China's ambitious multi-city bulk procurement program provides an opening for Indian manufacturers to compete.

Sun pharma falls after report of fresh whistle-blower complaint

Shares of India’s largest drugmaker fell as much as 13.2 percent.

On Camera

Nick Jonas wearing a mangalsutra is validation for many Indians. He’s our favourite jiju

Nick Jonas is not trying to modernise the mangalsutra, but his gesture shows that choices can be equal. If commitment must be flaunted, it need not be gendered.

In the West, there’s anxiety. In India, optimism—Rishi Sunak says India poised to be leader in AI

On Wednesday, the former UK Prime Minister Rishi Sunak was speaking in New Delhi at a Carnegie & Observer Research Foundation event on AI.

In a first, Indian small arms maker to bid for UK Project Grayburn to replace British Army’s SA80 rifles

Bengaluru-based SSS Defence has made public its bid for a major foreign military contract, targeting UK’s ambitious SA80 successor programme with its home-tested weapons.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.